Cronos Group Future Growth
Future criteria checks 4/6
Cronos Group is forecast to grow earnings and revenue by 62.4% and 10.3% per annum respectively. EPS is expected to grow by 57.3% per annum. Return on equity is forecast to be -3.3% in 3 years.
Key information
60.0%
Earnings growth rate
54.0%
EPS growth rate
| Pharmaceuticals earnings growth | 22.8% |
| Revenue growth rate | 10.2% |
| Future return on equity | -3.3% |
| Analyst coverage | Good |
| Last updated | 02 May 2024 |
Recent future growth updates
Recent updates
Cronos Stock: Attractive Now With Cannabis Legalization In Germany
Mar 04Cronos Group: Flush With Cash And Trading Below Book Value
Feb 11Cronos Group GAAP EPS of -$0.05 beats by $0.01, revenue of $23.1M misses by $5.25M
Aug 09Cronos Group: Too Much Cash, Too Soon - Making The Bear Case
Aug 01Cronos Group: High Hurdles
May 11Cronos Earnings: Cannabis Stock With 65% Net Cash And 51% Revenue Growth
Mar 01Cronos Group Late-Filed Q3-2021 Earnings Show Revenues From Synthetic Cannabinoids
Feb 22Cronos Group: Still No Reason To Own
Jan 22Cronos Group Strategic Investor Altria May Be About To Buy The Balance
Nov 08After Cronos Finally Invests In U.S. Cannabis, Is The Stock A Buy?
Aug 30Is Cronos Stock Worth Buying? Probably, But Patience Remains A Requirement
Jul 12Cronos Group stock rises 2.6% with acquisition of 10.5% stake in PharmaCann
Jun 14Cronos Group: Still Hasn't Launched
May 09Cronos Group Q1 Earnings Preview
May 06Cronos: The Most Confusing Cannabis Stock
Apr 28Cronos: Sitting On Your Hands Is Not A Winning Strategy
Jan 03Cronos Group (CRON) Investor Presentation - Slideshow
Nov 24Cronos Is A Buy With Increasing Revenues
Nov 18Cronos shares rise 5% on solid Q3 beat; top-line +96% boosted by advancement in Canadian/Israeli market
Nov 05Cronos: Failure To Launch
Nov 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 135 | 2 | -15 | -1 | 3 |
| 12/31/2025 | 121 | -11 | -13 | -8 | 5 |
| 12/31/2024 | 101 | -13 | -13 | -2 | 7 |
| 12/31/2023 | 87 | -70 | -46 | -43 | N/A |
| 9/30/2023 | 91 | -115 | -86 | -84 | N/A |
| 6/30/2023 | 86 | -146 | -101 | -97 | N/A |
| 3/31/2023 | 87 | -155 | -108 | -103 | N/A |
| 12/31/2022 | 87 | -155 | -94 | -89 | N/A |
| 9/30/2022 | 91 | -213 | -105 | -101 | N/A |
| 6/30/2022 | 91 | -102 | -124 | -119 | N/A |
| 3/31/2022 | 85 | -263 | -147 | -141 | N/A |
| 12/31/2021 | 65 | -127 | -166 | -154 | N/A |
| 9/30/2021 | 66 | -373 | -179 | -156 | N/A |
| 6/30/2021 | 57 | -381 | -181 | -153 | N/A |
| 3/31/2021 | 51 | -310 | -188 | -153 | N/A |
| 12/31/2020 | 47 | -72 | -180 | -145 | N/A |
| 9/30/2020 | 37 | 101 | -185 | -160 | N/A |
| 6/30/2020 | 31 | 636 | -186 | -152 | N/A |
| 3/31/2020 | 29 | 929 | -192 | -155 | N/A |
| 12/31/2019 | 24 | 1,167 | -170 | -131 | N/A |
| 9/30/2019 | 21 | 1,089 | -131 | -59 | N/A |
| 6/30/2019 | 18 | 479 | -130 | -49 | N/A |
| 3/31/2019 | 13 | 293 | -104 | -11 | N/A |
| 12/31/2018 | 12 | -21 | -96 | -8 | N/A |
| 9/30/2018 | 9 | -8 | -103 | -28 | N/A |
| 6/30/2018 | 7 | -1 | -73 | -16 | N/A |
| 3/31/2018 | 5 | -2 | -51 | -13 | N/A |
| 12/31/2017 | 3 | -1 | -37 | -4 | N/A |
| 9/30/2017 | 4 | 1 | N/A | -4 | N/A |
| 6/30/2017 | 2 | 0 | N/A | -8 | N/A |
| 3/31/2017 | 1 | -1 | N/A | -6 | N/A |
| 12/31/2016 | 0 | -1 | N/A | -5 | N/A |
| 9/30/2016 | 2 | 0 | N/A | -3 | N/A |
| 6/30/2016 | 2 | 0 | N/A | -2 | N/A |
| 3/31/2016 | 3 | 1 | N/A | -1 | N/A |
| 12/31/2015 | 2 | 0 | N/A | -1 | N/A |
| 9/30/2015 | 0 | -4 | N/A | -2 | N/A |
| 6/30/2015 | -1 | -4 | N/A | -2 | N/A |
| 3/31/2015 | -1 | -4 | N/A | -2 | N/A |
| 12/31/2014 | -1 | -4 | N/A | -1 | N/A |
| 9/30/2014 | 0 | -2 | N/A | -1 | N/A |
| 6/30/2014 | 0 | -1 | N/A | -1 | N/A |
| 12/31/2013 | 0 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRON is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: CRON is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CRON is expected to become profitable in the next 3 years.
Revenue vs Market: CRON's revenue (10.3% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: CRON's revenue (10.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CRON is forecast to be unprofitable in 3 years.